InvestorsHub Logo
Followers 1
Posts 189
Boards Moderated 0
Alias Born 12/27/2007

Re: None

Monday, 12/19/2011 6:07:14 PM

Monday, December 19, 2011 6:07:14 PM

Post# of 16714
Website updade regarding FDA Approval:

December 19, 2011: NanoLogix Instructs Battelle to Prepare US FDA Submittals

NanoLogix has instructed Battelle BioMedical Research Center to prepare the following for submittal to the US FDA, for a total of six separate applications.

1) Results of Battelle TB tests for approval for use as a BSL-3 test process for Tuberculosis using NanoLogix BNP technology

2) Results of the University of Texas Health Science Center-Houston Group B Streptoccocus tests (currently ongoing) for use as a recognized test kit using NanoLogix BNF technology

3) Results of multiple tests performed by Battelle on gram-positive bacteria with BNP and BNF technologies for approval as recognized tests for the gram-positive family of bacteria

4) Results of multiple tests performed by Battelle on gram-negative bacteria with BNP and BNF technologies for approval as recognized tests for the gram-negative family of bacteria

All tests and data collection have been performed by independent third-party laboratories and will be submitted to the US FDA by third parties. As such, NanoLogix does not control the timeline for the submission process.